TABLE 1.
Samples included in the studya
| Disease | Abbreviation | Sample type | No. of samples subjected to: |
|
|---|---|---|---|---|
| Microbial enrichment | Shotgun sequencing | |||
| Acute myeloid leukemia | AML | Bone marrow (sorted cells) | 9 | |
| B-cell chronic lymphocytic leukemia | B-CLL | Blood/bone marrow (sorted cells) | 9 | |
| B-cell precursor acute lymphoblastic leukemia | BCP-ALL | Bone marrow | 8 | |
| Basal cell carcinoma | BCC | Tumor biopsy specimens | 11 | 11 |
| Bladder cancer | Tumor biopsy specimens | 7 | ||
| Breast cancer (ductal/lobular) | Tumor biopsy specimens | 17 | 20 | |
| Ascitic fluid | 1 | 1 | ||
| Chronic myelogenous leukemia | CML | Bone marrow (sorted cells) | 10 | |
| Colon cancer | Tumor biopsy specimens | 3 | 12 | |
| Blood | 8 | |||
| Ascitic fluid | 1 | |||
| Lymphoma/myeloma | Cell lines | 12 | ||
| Malignant melanoma | Tumor biopsy specimens | 10 | 10 | |
| Mycosis fungoides (cutaneous T-cell lymphoma) | Mycosis | Tumor biopsy specimens | 11 | 11 |
| Oropharyngeal/oral cavity cancer | Oral | Tumor biopsy specimens | 10 | 9 |
| Ovarian cancer | Ascitic fluid | 3 | 5 | |
| Pancreatic cancer | Ascitic fluid | 2 | ||
| T-lineage acute lymphoblastic leukemia | T-ALL | Bone marrow (nonsorted/sorted cells) | 11 | |
| Testicular cancer (sem/non-sem) | Testis | Tumor biopsy specimens | 20 | 5 |
| Vulva cancer | Vulva | Tumor biopsy specimens | 3 | |
| Total no. of sample types and samples | 20 | 143 | 107 | |
a
The diseases, sample types, and number of samples included are shown.